variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
APOE-C130R,APOE,"This is generally known as the ApoE4 allele of ApoE and is associated with increased risk of Alzheimer's. 20-25% of individuals are heterozygous for this variant, and 1-2% are homozygous. Data from Khachaturian et al. suggests an average 7% of all individuals developed Alzheimer's by the age of 80; when this is split by ApoE4 status: 10% of ApoE4 heterozygotes (3% increased attributable risk), 40% of ApoE4 homozygotes (33% increased attributable risk), and 5% of non-carriers (2% decreased attributable risk). Notably, their model suggests 70-75% of people would eventually develop Alzheimer's by the age of 100 regardless of ApoE4 genotype (and 25-30% are resistant, regardless of genotype), but that ApoE4 variants shift the disease onset to occur significantly earlier (4 years earlier for heterozygous carriers, 13 years for homozygotes).",High,Well-established,Pathogenic,0.14,Mental and behavioral;Nervous system,Complex/Other,Heterozygous,9343467;11950276;15123497;17428983,rs429358,4,chr19,45411941,C,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
WNT10A-F228I,WNT10A,"Causes ectodermal dysplasia in a recessive manner (malformations of teeth and nails, abnormal/loss of sweating). Although reports have high statistical significance, allele frequency for this variant is high relative to the incidence of the disease. This suggests it may be milder than other pathogenic variants and cause disease with less than 100% penetrance and/or that the disease is more common than reported. Bohring et al. report heterozygotes for pathogenic variants in this gene often have milder skin, tooth, and nail abnormalities, with males having a higher rate of tooth abnormalities.",Moderate,Well-established,Pathogenic,0.019,"Mouth, liver, and digestive;Skin",Unknown,Heterozygous,19559398;20979233,,5,chr2,219755011,A,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
C3-R102G,C3,"This variant (also called C3F) is common in Europeans (10.2% allele frequency), and is associated with age-related macular degeneration. In the US, 1.5% of adults over 40 have the disease, but the incidence increases strongly with age (>15% in women over 80). Assuming an average lifetime risk of ~10%, heterozygous individuals have a ~13% risk and homozygous have ~20%.",Moderate,Likely,Pathogenic,0.15,Hearing and vision,Complex/Other,Heterozygous,4427677;17634448,rs2230199,3,chr19,6718387,C,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
SLC4A1-E40K,SLC4A1,"Rare and reported to cause hemolytic anemia in a recessive manner, although insufficient data is published to establish statistical significance. Polyphen 2 predicts a benign effect.",Moderate,Uncertain,Pathogenic,0.012,Blood,Recessive,Heterozygous,8471774,rs45562031,5,chr17,42338993,T,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
RPGRIP1L-A229T,RPGRIP1L,"This variant is generally not considered pathogenic, but when combined with other severe variants it is associated with rare genetic diseases which involve retinal degeneration. Carrying this variant increases the risk of these diseases, but the overall increased risk is very small because the diseases are very rare.",Low,Likely,Pathogenic,0.056,Hearing and vision,Unknown,Heterozygous,19430481,rs61747071,0,chr16,53720436,T,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
KRT5-G138E,KRT5,"This variant is associated with 1.25x increased risk of basal cell carcinoma (common skin cancer, rarely malignant).",Low,Likely,Pathogenic,0.052,Cancer;Skin,Unknown,Heterozygous,19578363,rs11170164,3,chr12,52913668,T,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Heterozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
AMPD1-Q12X,AMPD1,"Causes Adenosine Deaminase Deficiency in a recessive manner. Most of the time individuals do not report symptoms, but when symptoms do exist they to be post-exercise symptoms of muscle weakness, muscle pain, and getting tired more quickly.",Low,Likely,Pathogenic,0.093,"Metabolism;Muscular, skeletal, and connective tissue",Recessive,Heterozygous,1631143,rs17602729,4,chr1,115236057,A,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Homozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
LRP5-A1330V,LRP5,"In a study of a UK population this variant was associated with a small increased risk of osteoporosis and osteoporotic bone fractures, with each copy of the variant presumed to have an additive effect. A study in Chinese young men failed to find an association with peak bone density.

 
",Low,Uncertain,Pathogenic,0.11,"Muscular, skeletal, and connective tissue",Complex/Other,Heterozygous,18455228;19148563;20953208,rs3736228,2,chr11,68201295,T,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Heterozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
HFE-H63D,HFE,"There have been some hypotheses that this variant contributes to causing hereditary hemochromatosis, possibly as a compound heterozygote, but some others treat it as a polymorphism. Cys282Tyr is the classic causal variant and itself has very low penetrance. Mouse studies indicates this variant has a similar but weaker effect; if it has any effect at all its penetrance may be quite low and/or require modifier alleles.",Low,Uncertain,Pathogenic,0.11,Blood,Recessive,Heterozygous,8696333;9462220;12429850;14673107;17042772,rs1799945,1,chr6,26091179,G,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
BRCA2-N372H,BRCA2,"This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.",Low,Uncertain,Pathogenic,0.24,Cancer,Recessive,Heterozygous,11062481;15235023,rs144848,2,chr13,32906729,C,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Heterozygous,,rs1544410,0,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Homozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
CCR5-S185Shift,CCR5,"Also known as CCR5-delta32, this variant is associated with resistance to many strains of HIV (but not all strains, only strains that use target the CCR5 protein). Heterozygotes are reported to have slower HIV progression, and homozygotes are very resistant to being infected by these strains.",Low,Well-established,Protective,0.048,Immune system,Recessive,Heterozygous,8751444;8791590;8898752,rs333,1,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Homozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
MTR-D919G,MTR,"This variant was weakly associated with a protective effect vs. colorectal cancer, but only in individuals with low alcohol consumption.


",Low,Uncertain,Protective,0.22,Cancer,Complex/Other,Heterozygous,10498402;14744749;17417062;17855192,rs1805087,1,chr1,237048500,G,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
LPL-S474X,LPL,"This variant actually increases LPL enzyme activity despite creating a termination codon (see Rip J et al). It appears to be a protective variant, associated with lower triglyceride levels--although the effect is quite weak and explains only 0.5-1% of triglyceride variation.",Low,Uncertain,Protective,0.084,Metabolism,Unknown,Heterozygous,16574898;17463246;18193044;19802338;20429872;22042884,rs328,,chr8,19819724,G,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
IRS2-G1057D,IRS2,"a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. 
A longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ",Low,Uncertain,Protective,0.23,Other,Unknown,Heterozygous,19887537,rs1805097,,chr13,110435231,T,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
OCA2-R419Q,OCA2,"This variant is associated with eye color, as is OCA2 R305W. Individuals with this variant are reported to be more likely to have green/hazel eyes as opposed to blue/gray eyes. Other variants in this gene are associated with oculocutaneous albinism (albinism which involves skin and eyes).",Low,Likely,Benign,0.057,Hearing and vision;Skin,Unknown,Heterozygous,12163334,rs1800407,,chr15,28230318,T,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
EFHC1-R182H,EFHC1,Probably benign. OMIM appears to incorrectly interpret literature as linking this variant to juvenile myoclonic epilepsy; the authors report it as a polymorphism.,Low,Likely,Benign,0.044,Nervous system,Unknown,Heterozygous,7668263;15258581,rs3804505,,chr6,52303361,A,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
PMS2-P470S,PMS2,"Benign, common variant.",Low,Likely,Benign,0.37,Other,Unknown,Heterozygous,15256438,rs1805321,,chr7,6026988,A,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
KEL-T193M,KEL,This variant is also known as Kell or K1 or K (capitalized) in the Kell antigen system. K1-negative mothers (carrying no copies of this variant) carrying K1-positive fetuses (heterozygous or homozygous) are at risk for hemolytic disease of the newborn. About 9% of caucasians carry one or two copies of K1.,Low,Uncertain,Benign,0.032,Blood,Dominant,Heterozygous,7849312,rs8176058,,chr7,142655008,A,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
COL4A4-G999E,COL4A4,"This variant is causative for Benign Familial Hematuria (thin membrane basement disease). While this variant is benign, it is useful in differentiating glomerular hematuria from Alport Syndrome.",Low,Uncertain,Benign,0.01,Blood,Dominant,Heterozygous,12631110;14871398,rs13027659,,chr2,227915847,T,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
DCTN1-R1049Q,DCTN1,"Although rare and predicted to have a damaging effect, Vilarino-Guell et al. find the variant did not segregate with neurological disease and conclude it is not deleterious.",Low,Uncertain,Benign,0.0014,Nervous system,Unknown,Heterozygous,19506225,rs72659383,,chr2,74592252,T,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
ELN-G581R,ELN,"Probably a benign SNP, not rare (4.8% allele frequency in GET-Evidence data).",Low,Uncertain,Benign,0.073,Other,Unknown,Heterozygous,,rs17855988,,chr7,73474825,C,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
AMPD1-P48L,AMPD1,"Probably benign, ancestral to15173240 pathogenic Q12X mutation.",Low,Uncertain,Benign,0.094,Other,Unknown,Heterozygous,15173240,rs61752479,,chr1,115231254,A,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
F5-D2222G,F5,"Other mutations in this gene are associated with Factor 5 deficiency. There is no literature implicating this variant, however, and it is fairly common in the population (3.8% in HapMap), and so it is currently labeled as benign.",Low,Uncertain,Benign,0.045,Blood,Unknown,Heterozygous,,rs6027,,chr1,169483561,C,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
F5-M413T,F5,Presumed benign. This variant is not particularly rare and has not been reported to cause disease.,Low,Uncertain,Benign,0.058,Other,Unknown,Heterozygous,17284699,rs6033,,chr1,169521853,G,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Heterozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
MAPT-R370W,MAPT,Probably benign.,Low,Uncertain,Benign,0.16,Other,Unknown,Heterozygous,15365985,rs17651549,,chr17,44061278,T,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Homozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Homozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.personalgenomes.org/genomes?display_genome_id=dced0013a0f3bc51f7dad079925fca3bd2aa4d7c&access_token=437c77f2ea1aa73c318c97c44705ed03
